A U.S. vaccine material producer pledged to invest millions into South Korea.
President Moon sat down with the head of Pfizer to discuss multilateral cooperation.
He’s also promised to provide Vietnam with one million vaccine doses.
Han Seong-woo sheds light on how the country inches closer to becoming a global vaccine hub.
American vaccine material producer Cytiva will invest 52.5 million U.S. dollars in South Korea from 2022 to 2024.
At the announcement on Tuesday, U.S. local time, was South Korean President Moon Jae-in who expects the investment to help establish a stable supply chain for vaccine materials and contribute to South Korea's journey toward becoming a global vaccine hub.
We hope the combination of the United States' excellent development capabilities and South Korea's global production capacity can lead to a vast increase in the production and supply of vaccines.
Cytiva's decision marks the first time a global vaccine material producer has agreed to invest in a new manufacturing facility in Korea since the start of the pandemic.
The company will be producing disposable cell culture fluid, a vaccine material in short supply worldwide.
Earlier in the day, President Moon met with Pfizer chairman and CEO Albert Bourla to discuss the country's plan to secure additional supplies of the pharmaceutical giant's mRNA vaccines next year.
Stressing how important it is to receive them early, the President thanked Pfizer for its contribution so far and requested its support moving forward.
Half of Korea's vaccine recipients have received Pfizer. The Pfizer shot has become the most trusted vaccine among Koreans.
"I want to assure you Mr. President that Pfizer will do everything that we can to stay close to you and your government and the Korean people and to help as much as we can."
Meanwhile, South Korea has decided to provide Vietnam with at least one million vaccine doses in October.
The plan was unveiled during Moon's summit talks with Vietnamese president Nguyen Xuan Phuc in New York on the sidelines of the UN General Assembly.
It will be the first time that South Korea has given vaccines to a foreign nation directly, rather than through the COVAX program.
This comes amid an agreement to deepen strategic ties as the two nations prepare for the 30th anniversary of the establishment of diplomatic relations next year.
Han Seong-woo, Arirang News.